ClinicalTrials.gg
CompletedNCT03339739Updated Nov 13, 2017

Effects of Mandibular Exercises Effect on Pain Perception and Sensitivity in Mandibular Myofascial Pain

An interventional study of Isometric mandibular exercises and Isotonic mandibular exercises in Temporomandibular Disorders, sponsored by Universidad Nacional Andres Bello. Completed. Open to female participants aged 18 Years to 26 Years. Per ClinicalTrials.gov, last updated 2017-11-13.

Sponsored by Universidad Nacional Andres Bello · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years after the study started (first participant enrolled Oct 2014, registered Oct 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Randomized
Ages
18 Years to 26 Years
Sex
Female
01

Study summary

The effectiveness of mandibular exercises as a treatment of muscular Orofacial Pain is yet unknown. This study hypothesized that training exercises can be an effective therapy improving pain perception.

Read the detailed description

Temporomandibular disorders (TMDs) represent heterogeneous musculoskeletal disorders, where most common presentation is mandibular muscle pain, which is also more common among female than men. Many interventions have been proposed for this pain control, regarding drugs, oral splints, relaxing exercises and self awareness but little is known about mandibular active contraction exercises. The aim of this study is to evaluate the effects of mandibular exercises in pain perception and sensitivity in women. A double blind randomized clinical trial will be conducted among fertile university student women with Oral Contraceptives (OC) use -to control hormonal influences-, with report of facial pain and myofascial pain diagnosis (RDC/TMD). They will be assessed in Visual analogue scale (VAS), sleep quality, Pressure Pain Threshold (PPT) and pressure pain tolerance (PPTol), and then allocated in one of the three interventions for 21 days: isometric mandibular active exercises over silicone bars; video-guided isotonic mandibular contractions over cloth pegs or counseling about disorders nature as passive comparison. After 21 days, VAS, PPT and PPTol in bilateral temporalis and masseter muscles will be assessed for a second time,) and compared with initial pain status.

Data will be entered by single blind operator, and will be open for quality auditing. Site monitoring will be performed by the University clinical entities.

Data checks will be also performed as planned. Descriptive and analytical statistics will be performed to address the primary and secondary objectives.

02

Conditions studied

  • Temporomandibular Disorders

Keywords

  • Musculoskeletal Pain
  • Orofacial Pain
  • Physical Therapy Modalities
  • Oral Contraceptives
  • Mandibular Diseases
  • Muscular Diseases
  • Risk factors
  • Contraceptive Usage
  • Pain, Chronic
  • Craniomandibular Disorders
03

In context

Temporomandibular Joint Disorders

591 studies on the registry are indexed under Temporomandibular Joint Disorders; 149 are open to participants now.

This study's enrollment of 45 is close to the median of 45 across 415 interventional studies indexed under Temporomandibular Joint Disorders.

Browse Temporomandibular Joint Disorders studies →

Lead sponsor

Universidad Nacional Andres Bello is the lead sponsor of 23 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 26 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Temporomandibular Myofascial pain diagnosis
  • Oral consumption
  • Facial pain for at least 3 months (and at least 10 of the last 30 days at Visit 0)
  • Agrees to terms for continuing/discontinuing certain prescription/over-the-counter pain medications.

Exclusion criteria

Exclusion Criteria:

  • Other orofacial pain diagnosis
  • Oral surgery within 6 months
  • Treatment for pain management within past 30 days
  • Neurological or psychiatric disorders
  • Orthodontic treatment
  • History of pregnancy, pregnancy or breastfeeding.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
45 participants (actual)

Study arms

  • Experimental
    Isometric exercise Group

    Group of participants which perform Isometric mandibular exercises, once a day, for 21 days

    Other: Isometric mandibular exercises

  • Active comparator
    Isotonic exercise Group

    Group of participants which perform Isotonic mandibular exercises, once a day, for 21 days

    Other: Isotonic mandibular exercises

  • Placebo comparator
    Counseling Group

    Group of participants which receive education brochure and no further interventions.

    Behavioral: Counseling group

Interventions

  • OtherIsometric mandibular exercises

    daily video guided three-minutes routine in 21 days (days of OC consumption) of soft clenching over three millimeters silicone bars bilaterally on molars

  • OtherIsotonic mandibular exercises

    daily video guided three-minutes routine in 21 days (days of OC consumption) of isotonic dynamic contraction over calibrated cloth pegs on central incisors

  • BehavioralCounseling group

    subjects included in this group get an education brochure about the disorder and receive no further interventions

06

What researchers measure

Primary outcomes

  1. Change in the weekly mean subjective pain index after 21 days of treatment

    Weekly mean subjective pain computed as the arithmetic mean of daily pain subjective values (visual analog scale - VAS) in Visit 1and prior to each study visit. Daily pain index is computed as pain intensity (0-100 numeric rating scale where 0 = "no pain" and 100 = "the most intense pain imaginable") for the different muscular sites tested.

    Time frame: Visit 1 (study day 0) and Visit 4 (study day 3) ( duration study 21 days)

  2. Change in the weekly mean pressure pain threshold (PPT) after 21 days of treatment

    Weekly mean pressure pain threshold is computed as the arithmetic mean of daily pressure pain threshold values for muscular sites in Visit 1and prior to each study visit. Pressure values, measured in kilogram-force (kgf), from up to 3 experimental pressure stimuli, bilaterally applied to the area of temporalis muscle, will be averaged to obtain a single pressure pain threshold value per anatomical site.

    Time frame: Visit 1 (study day 0) and Visit 4 (study day 3) ( duration study 21 days)

  3. Change in the weekly mean pressure pain tolerance (PPTol) after 21 days of treatment

    Weekly mean pressure pain tolerance is computed as the arithmetic mean of daily pressure pain tolerance values for muscular sites in Visit 1and prior to each study visit. Plot is captured as a pressure value, measured in kilogram-force (kgf) in 1 experimental pressure stimuli, bilaterally applied per anatomical muscle site.

    Time frame: Visit 1 (study day 0) and Visit 4 (study day 3) ( duration study 21 days)

Secondary outcomes

  1. Change in pressure pain threshold at temporalis muscle after 1 week of treatment

    Pressure values, measured in kilogram-force (kgf), from up to 3 experimental pressure stimuli, bilaterally applied to the area of temporalis muscle, will be averaged to obtain a single pressure pain threshold value per anatomical site.

    Time frame: Visit 1 (study day 0) and Visit 2 (study day 7) ( 7 days in between)

  2. Change in pressure pain threshold at temporalis muscle after 2 weeks of treatment

    Pressure values, measured in kilogram-force (kgf), from up to 3 experimental pressure stimuli, bilaterally applied to the area of temporalis muscle, will be averaged to obtain a single pressure pain threshold value per anatomical site.

    Time frame: Visit 1 (study day 0) and Visit 2 (study day 14) ( 7 days in between)

  3. Change in pressure pain threshold at temporalis muscle after 3 weeks of treatment

    Pressure values, measured in kilogram-force (kgf), from up to 3 experimental pressure stimuli, bilaterally applied to the area of temporalis muscle, will be averaged to obtain a single pressure pain threshold value per anatomical site.

    Time frame: Visit 1 (study day 0) and Visit 2 (study day 21) ( 7 days in between)

  4. Change in pressure pain threshold at masseter muscle after 1 week of treatment

    Pressure values, measured in kilogram-force (kgf), from up to 3 experimental pressure stimuli, bilaterally applied to the area of masseter muscle, will be averaged to obtain a single pressure pain threshold value per anatomical site.

    Time frame: Visit 1 (study day 0) and Visit 2 (study day 7) ( 7 days in between)

  5. Change in pressure pain threshold at masseter muscle after 2 weeks of treatment

    Pressure values, measured in kilogram-force (kgf), from up to 3 experimental pressure stimuli, bilaterally applied to the area of masseter muscle, will be averaged to obtain a single pressure pain threshold value per anatomical site.

    Time frame: Visit 1 (study day 0) and Visit 2 (study day 14) ( 14 days in between)

  6. Change in pressure pain threshold at masseter muscle after 3 weeks of treatment

    Pressure values, measured in kilogram-force (kgf), from up to 3 experimental pressure stimuli, bilaterally applied to the area of t masseter muscle, will be averaged to obtain a single pressure pain threshold value per anatomical site.

    Time frame: Visit 1 (study day 0) and Visit 2 (study day 21) ( 21 days in between)

  7. Change in pressure pain tolerance at temporalis muscle after 1 week of treatment

    Pressure pain tolerance is captured as a pressure value, measured in kilogram-force (kgf) in 1 experimental pressure stimuli, bilaterally applied to the area of temporalis muscle.

    Time frame: Visit 1 (study day 0) and Visit 2 (study day 7) ( 7 days in between)

  8. Change in pressure pain tolerance at temporalis muscle after 2 weeks of treatment

    Pressure pain tolerance is captured as a pressure value, measured in kilogram-force (kgf) in 1 experimental pressure stimuli, bilaterally applied to the area of temporalis muscle.

    Time frame: Visit 1 (study day 0) and Visit 2 (study day 14) ( 14 days in between)

  9. Change in pressure pain tolerance at temporalis muscle after 3 weeks of treatment

    Pressure pain tolerance is captured as a pressure value, measured in kilogram-force (kgf) in 1 experimental pressure stimuli, bilaterally applied to the area of temporalis muscle.

    Time frame: Visit 1 (study day 0) and Visit 2 (study day 21) ( 21 days in between)

  10. Change in pressure pain tolerance at masseter muscle after 1 week of treatment

    Pressure pain tolerance is captured as a pressure value, measured in kilogram-force (kgf) in 1 experimental pressure stimuli, bilaterally applied to the area of masseter muscle.

    Time frame: Visit 1 (study day 0) and Visit 2 (study day 7) ( 7 days in between)

  11. Change in pressure pain tolerance at masseter muscle after 2 weeks of treatment

    Pressure pain tolerance is captured as a pressure value, measured in kilogram-force (kgf) in 1 experimental pressure stimuli, bilaterally applied to the area of masseter muscle.

    Time frame: Visit 1 (study day 0) and Visit 2 (study day 14) ( 14 days in between)

  12. Change in pressure pain tolerance at masseter muscle after 3 weeks of treatment

    Pressure pain tolerance is captured as a pressure value, measured in kilogram-force (kgf) in 1 experimental pressure stimuli, bilaterally applied to the area of masseter muscle.

    Time frame: Visit 1 (study day 0) and Visit 2 (study day 21) ( 21 days in between)

  13. Change in the Pittsburgh Sleep Quality Index (PSQI) global score after 21 days of treatment

    The PSQI has 19 items grouped into 7 component scores, each weighted equally on a 0-3 scale. The 7 component scores are summed to obtain a global score, which has a range of 0-21.

    Time frame: Visit 1 (study day 0) and Visit 4 (study day 3) ( duration study 21 days)

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — no plan

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 13, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03339739
Lead sponsor
Universidad Nacional Andres Bello
Responsible party
Juan Fernando Oyarzo (Orofacial Pain & TMD Professor, Universidad Nacional Andres Bello) — Principal investigator
First posted
Nov 13, 2017
Start date
Oct 18, 2014
Primary completion
Dec 6, 2016
Completion
Dec 30, 2016
Last update
Nov 13, 2017

Study contacts

Juan F Oyarzo, Prof
principal investigator · Universidad Andres Bello

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion